肺癌早期综合诊疗思考

Forepart Integrative Treatment of Lung Cancer

通过分析目前肺癌患者5年生存率徘徊在10%,这一现实问题,可以得到一些重要启示和思考。今后肺癌治疗发展方向将是完善个体化、多学科早期综合治疗模式;利用基因芯片技术开展肺癌早期诊断,对肺癌高危人群开展大规模普查;开展靶向性、高效低毒、抗耐药性的肺癌治疗药物研究,进行肺癌逆转的分子干预治疗和分子阻断治疗,要用早期综合地手段诊疗肺癌。

To analyze excellence and shortcoming of single therapeutic method in Lung Cancer that exist rate was 10 percent for five years at present,we ean get some important illumination and thought, from now on lung cancer treatment direction will be consummating individuation, multiple subjects early eornbined therapy ,use gene array technique to develop lung cancer early diagnosis,develop large scale survey to lung cancer high risk group ,develop targeting high efficient low poison ,anti - drug resister lung cancer therapeutic drug research , carry out lung cancer reverse molecule intervention treatment and molecule block treatment. It leads us to treat lung cancer with synthetic and forepart means.